(Q36461969)

14 August 2017

Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials (English)

1 reference

14 August 2017

multivariate statistics

1 reference

1

Yanqing Sun

1 reference

14 August 2017

Mei Li

2

1 reference

PMC publication ID

3520499

14 August 2017

Peter B Gilbert

series ordinal

3

1 reference

14 August 2017

3 July 2012

1 reference

14 August 2017

1 reference

14 August 2017

14

1 reference

14 August 2017

1

1 reference

14 August 2017

60-74

1 reference

Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

The Analysis of Failure Times in the Presence of Competing Risks

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Leveraging information across HLA alleles/supertypes improves epitope prediction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Tests for comparing mark-specific hazards and cumulative incidence functions

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520499

The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22764174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/BIOSTATISTICS/KXS022

1 reference

14 August 2017

1 reference

PMC publication ID

3520499

14 August 2017

PubMed publication ID

22764174

1 reference

PMC publication ID

3520499